judges scientific - JSCIF

JSCIF

Close Chg Chg %
75.93 -1.72 -2.27%

Closed Market

74.21

-1.72 (2.27%)

Volume: 200.00

Last Updated:

Feb 5, 2026, 12:03 PM EDT

Company Overview: judges scientific - JSCIF

JSCIF Key Data

Open

$68.27

Day Range

68.27 - 74.21

52 Week Range

59.00 - 120.88

Market Cap

$505.73M

Shares Outstanding

6.66M

Public Float

5.94M

Beta

0.45

Rev. Per Employee

N/A

P/E Ratio

34.65

EPS

N/A

Yield

187.24%

Dividend

$0.44

EX-DIVIDEND DATE

Oct 9, 2025

SHORT INTEREST

N/A

AVERAGE VOLUME

772.32

 

JSCIF Performance

1 Week
 
2.36%
 
1 Month
 
-5.46%
 
3 Months
 
-6.13%
 
1 Year
 
N/A
 
5 Years
 
N/A
 

JSCIF Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About judges scientific - JSCIF

Judges Scientific Plc is engaged in the design and production of scientific instruments. It operates through following business segments: Materials Sciences and Vacuum. The Materials Sciences segment supplies measurement equipment across both public and private sectors. The Vacuum segment designs and manufactures instruments to prepare samples for examination in electron microscopes and to create motion, heating and cooling within ultra high vacuum chambers. Judges Scientific was founded by David Elie Cicurel and Alexander Robert Hambro on November 21, 2002 and is headquartered in London, the United Kingdom.

JSCIF At a Glance

Judges Scientific Plc
52c Borough High Street
London, London & South East SE1 1XN
Phone 44-203-829-6970 Revenue 170.72M
Industry Electronic Equipment/Instruments Net Income 13.29M
Sector Electronic Technology 2024 Sales Growth 0.908%
Fiscal Year-end 12 / 2025 Employees 767
View SEC Filings

JSCIF Valuation

P/E Current 34.653
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 52.837
Price to Sales Ratio 4.182
Price to Book Ratio 6.459
Price to Cash Flow Ratio 22.08
Enterprise Value to EBITDA 19.668
Enterprise Value to Sales 4.593
Total Debt to Enterprise Value 0.118

JSCIF Efficiency

Revenue/Employee 222,575.912
Income Per Employee 17,326.269
Receivables Turnover 5.049
Total Asset Turnover 0.696

JSCIF Liquidity

Current Ratio 2.275
Quick Ratio 1.436
Cash Ratio 0.534

JSCIF Profitability

Gross Margin 13.024
Operating Margin 13.024
Pretax Margin 9.731
Net Margin 7.784
Return on Assets 5.415
Return on Equity 12.427
Return on Total Capital 6.611
Return on Invested Capital 7.025

JSCIF Capital Structure

Total Debt to Total Equity 84.695
Total Debt to Total Capital 45.857
Total Debt to Total Assets 35.885
Long-Term Debt to Equity 83.314
Long-Term Debt to Total Capital 45.109
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Judges Scientific - JSCIF

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
125.55M 139.45M 169.18M 170.72M
Sales Growth
+22.59% +11.07% +21.32% +0.91%
Cost of Goods Sold (COGS) incl D&A
104.45M 113.56M 142.08M 148.48M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
6.54M 13.52M 19.14M 17.63M
Depreciation
2.90M 3.00M 3.98M 4.73M
Amortization of Intangibles
3.64M 10.51M 15.17M 12.91M
COGS Growth
+16.62% +8.73% +25.11% +4.51%
Gross Income
21.10M 25.88M 27.10M 22.23M
Gross Income Growth
+64.18% +22.65% +4.69% -17.95%
Gross Profit Margin
+16.81% +18.56% +16.02% +13.02%
2021 2022 2023 2024 5-year trend
SG&A Expense
- - - -
-
Research & Development
7.46M 10.21M 6.96M 8.94M
Other SG&A
(7.46M) (10.21M) (6.96M) (8.94M)
SGA Growth
- - - -
-
Other Operating Expense
- - 123.78K (146.58K)
-
Unusual Expense
(501.99K) 4.12M 6.71M 766.69K
EBIT after Unusual Expense
21.48M 21.91M 20.39M 21.47M
Non Operating Income/Expense
(63.26K) 177.37K 497.23K 127.78K
Non-Operating Interest Income
2.75K 209.40K 372.92K 383.34K
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
980.59K 2.42M 4.23M 4.98M
Interest Expense Growth
+16.92% +146.71% +74.70% +17.91%
Gross Interest Expense
980.59K 2.42M 4.23M 4.98M
Interest Capitalized
- - - -
-
Pretax Income
20.44M 19.67M 16.66M 16.61M
Pretax Income Growth
+68.24% -3.76% -15.31% -0.27%
Pretax Margin
+16.28% +14.10% +9.85% +9.73%
Income Tax
2.69M 3.93M 4.35M 2.81M
Income Tax - Current - Domestic
3.12M 2.62M 4.97M 3.07M
Income Tax - Current - Foreign
136.16K 816.67K 1.37M 638.91K
Income Tax - Deferred - Domestic
(565.25K) 500.10K (1.99M) (894.47K)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
17.75M 15.74M 12.31M 13.80M
Minority Interest Expense
305.32K 415.11K 497.22K 511.12K
Net Income
17.44M 15.32M 11.81M 13.29M
Net Income Growth
+65.47% -12.16% -22.92% +12.53%
Net Margin Growth
+13.89% +10.99% +6.98% +7.78%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
17.44M 15.32M 11.81M 13.29M
Preferred Dividends
- - - -
-
Net Income Available to Common
17.44M 15.32M 11.81M 13.29M
EPS (Basic)
2.7639 2.4155 1.8129 2.0029
EPS (Basic) Growth
+64.39% -12.61% -24.95% +10.48%
Basic Shares Outstanding
6.31M 6.34M 6.51M 6.63M
EPS (Diluted)
2.7259 2.3835 1.7836 1.9698
EPS (Diluted) Growth
+65.17% -12.56% -25.17% +10.44%
Diluted Shares Outstanding
6.40M 6.43M 6.62M 6.75M
EBITDA
27.52M 39.55M 46.24M 39.87M
EBITDA Growth
+43.06% +43.71% +16.93% -13.78%
EBITDA Margin
+21.92% +28.36% +27.33% +23.35%

Judges Scientific in the News